Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107689 · ClinicalTrials.gov registry record
Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 134
- Enrollment target
NCT03107689: Completed study, sponsored by University of Southern California.
NCT03107689 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03107689 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will permit a much more detailed description of the use of lipid, its potential benefits, and potential harms.
Primary Outcome
The primary objective is to compare survival based on lipophilicity (as measured by LogD) of the drugs
Interventions
- OTHER administration of intravenous lipid emulsion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-12 |
What the finished NCT03107689 record still lists
NCT03107689 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which administration of intravenous lipid emulsion is the first listed.
NCT03107689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03107689 about?
NCT03107689 is a clinical study titled "Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients". The purpose of this project is to evaluate the case characteristics of patients who receive intravenous lipid emulsion therapy. Previous literature to date has focused on animal studies or has been primarily limited to case reports or small case series. This prospectively collected data set will per...
What is the current status of trial NCT03107689?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2012-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT03107689?
The interventions under investigation include: administration of intravenous lipid emulsion (OTHER).
Who is sponsoring clinical trial NCT03107689?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia